US 8742119
Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
granted A61PA61P13/08A61P3/04
Quick answer
US patent 8742119 (Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use) held by Agios Pharmaceuticals, Inc. expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P13/08, A61P3/04, A61P3/10, A61P35/00